Compare BAFN & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | BAFN | NBY |
|---|---|---|
| Founded | 1999 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.9M | 31.6M |
| IPO Year | 2021 | 2007 |
| Metric | BAFN | NBY |
|---|---|---|
| Price | $5.87 | $1.23 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 16.1K | ★ 869.6K |
| Earning Date | 04-23-2026 | 03-31-2026 |
| Dividend Yield | ★ 1.39% | N/A |
| EPS Growth | ★ 133.93 | 35.42 |
| EPS | N/A | ★ 0.76 |
| Revenue | N/A | ★ $370,000.00 |
| Revenue This Year | N/A | $23.91 |
| Revenue Next Year | N/A | $32.05 |
| P/E Ratio | ★ N/A | $1.67 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.80 | $0.43 |
| 52 Week High | $19.00 | $19.95 |
| Indicator | BAFN | NBY |
|---|---|---|
| Relative Strength Index (RSI) | 43.65 | 42.69 |
| Support Level | N/A | $0.99 |
| Resistance Level | $8.37 | $1.36 |
| Average True Range (ATR) | 0.55 | 0.21 |
| MACD | -0.02 | 0.12 |
| Stochastic Oscillator | 47.82 | 14.19 |
BayFirst Financial Corp is a bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios. The company has various segment such as Real Estate(Residential, Commercial, and Construction & Land), Commercial and Industrial, Consumer.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.